Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Icu Medical (ICUI) over the last 16 years, with Q4 2024 value amounting to $4.4 million.

  • Icu Medical's Asset Writedowns and Impairment rose 1646666.67% to $4.4 million in Q4 2024 from the same period last year, while for Mar 2025 it was $5.3 million, marking a year-over-year increase of 62829.4%. This contributed to the annual value of $5.8 million for FY2024, which is 59212.41% up from last year.
  • As of Q4 2024, Icu Medical's Asset Writedowns and Impairment stood at $4.4 million, which was up 1646666.67% from $11000.0 recorded in Q3 2024.
  • Icu Medical's 5-year Asset Writedowns and Impairment high stood at $4.4 million for Q4 2024, and its period low was -$548000.0 during Q1 2022.
  • Over the past 5 years, Icu Medical's median Asset Writedowns and Impairment value was $457500.0 (recorded in 2022), while the average stood at $1.0 million.
  • Per our database at Business Quant, Icu Medical's Asset Writedowns and Impairment crashed by 15946.55% in 2023 and then surged by 1646666.67% in 2024.
  • Quarter analysis of 5 years shows Icu Medical's Asset Writedowns and Impairment stood at $4.4 million in 2020, then tumbled by 30.19% to $3.0 million in 2021, then crashed by 72.94% to $822000.0 in 2022, then plummeted by 103.28% to -$27000.0 in 2023, then soared by 16466.67% to $4.4 million in 2024.
  • Its Asset Writedowns and Impairment was $4.4 million in Q4 2024, compared to $11000.0 in Q3 2024 and $821000.0 in Q2 2024.